Treatment of CML CD34+ cells with EZH2 inhibitor GSK343

ABSTRACT: Transcriptional profiling by array of CML CD34+ cells to understand the response of chronic myeloid leukaemia stem cells to an EZH2 inhibitor, GSK343.

ORGANISM(S): Homo sapiens

SUBMITTER: Lisa Hopcroft 

PROVIDER: E-MTAB-2893 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress